Abstract
Treatment of inflammatory bowel disease (IBD) is hampered by the fact that we know very little about the underlying causes of this condition. For instance, it remains unclear whether those alterations in immunologic function (such as autosensitization to epithelial cell components)1 or in the activity or structure of the enteric nervous system (degeneration of the autonomic nerves)2 which are characteristic of IBD represent initiating factors or are simply epiphenomena. Consequently, treatment is primarily palliative or supportive. The development of new or improved therapeutic agents and procedures, in particular, would benefit from the availability of animal models on which newly developed agents which might be of value in treatment of human disease could be tested. In particular there is a need for models which are simple to produce, which are inexpensive, and in which the induced disease is sufficiently prolonged, reproducible and severe to enable such tests to be routinely performed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.K. Roche, C. Fiocchi, and K. Youngman, Sensitization to epithelial antigens in chronic mucosal inflammatory disease, J Clin Invest. 75:522 (1985).
A.M. Dvorak, What is the evidence for damaged enteric autonomic nerves in Crohn’s disease, in: “Inflammatory Bowel Disease: Current Status and Future Approach,” R.P. MacDermott, ed., Elsevier Science Publishers B.V., Amsterdam: (1988).
W. Strober, Animal models of inflammatory bowel disease -an overview, Dig Dis Sci. 30:3S (1985).
B. Macpherson, and C.J. Pfeiffer, Experimental colitis, Digestion. 14:424 (1976).
J.F. Mayberry, J. Rhodes, and R.V. Heatley, Infections which cause ileocolic disease in animals: are they relevant to Crohn’s disease, Gastroenterology. 78:1080 (1980).
R. Lindberg, Pathology of equine granulomatous enteritis, J Comp Path. 94:233 (1984).
J.L. Madara, D.K. Podolsky, N.W. King, P.K. Sehgal, R. Moore, and H.S. Winter, Characterization of spontaneous colitis in cotton-top tamarins (Saguinus oedipus) and its response to sulfasalazine, Gastroenterology. 88:13 (1985).
H.S. Winter, P.M. Crum, N.W. King, P.K. Sehgal, and J.K. Roche, Expression of immune sensitization to epithelial cell-associated components in the cotton-top tamarin: a model of chronic ulcerative colitis, Gastroenterology. 97:1075 (1989).
W. Strober, and S.P. James, The immunologic basis of inflammatory bowel disease, J Clin Immunol.6:415 (1986).
B.B. Crohn, L. Ginsberg, and G.D. Oppenheimer, Regional ileitis: a pathological and clinical entity,J Amer Med Assoc. 99:1323 (1932).
D.B. Sachar, Animal transmission models, Mt Sinai J Med. 50:166 (1983).
W.L. Beeken, Transmissible agents in inflammatory bowel disease: 1980, Med Clin N Am. 64:1021(1980).
W.L. Beeken, D.N. Mitchell, and D.R. Cave, Evidence for a transmissible agent in Crohn’s disease,Clin Gastroenterology. 5:289 (1976).
K.M. Das, I. Valenzuela, S.E. Williams, R. Soeiro, A.S. Kadish, and S.G. Baum, Studies on the etiology of Crohn’s disease using athymic nude mice, Gastrotenterology. 84:364 (1983).
J.F. Collins, R.G. Strickland, E.L. Kekahbah, M.H. Arthur, F. Naeim, and G.L. Gitnick,Histological response and antigen transmission in the lymph nodes of athymic nu/nu mice inoculated with Crohn’s disease tissue filtrates, Gut. 29:983 (1988).
H.C. Walvoort, G.E. Fazzi, and A.S. Pena, Seroreactivity of patients with Crohn’s disease with lymph nodes of primed nude mice is independent of the tissue used for priming, Gastroenterology. 97:1097 (1989).
R.J. Chiodini, H.J. Van Kruiningen, W.R. Thayer, R.S. Merkal, and J.A. Coutu, Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn’s disease, Dig Dis Sci. 29:1073 (1984).
W.R. Thayer, J.A. Coutu, R.J. Chiodini, H.J. Van Kruiningen, and R.S. Merkal, Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn’s disease, Dig Dis Sci. 29:1080(1984).
R.J. Chiodini, H.J. Van Kruiningen, R.S. Merkal, W.R. Thayer, and J.A. Coutu, Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn’s disease, J Clin Microbiol. 20:966 (1984).
H.J. Van Kruiningen, R.J. Chiodini, W.R. Thayer, J.A. Coutu, R.S. Merkal, and P.L. Runnels,Experimental disease in infant goats induced by a Mycobacterium isolated from a patient with Crohn’s disease. A preliminary report, Dig Dis Sci. 31:1351 (1986).
H.H. Yoshimura, D.Y. Graham, M.K. Estes, and R.S. Merkal, Investigation of association of mycobacteria with inflammatory bowel disease by nucleic acid hybridization, J Clin Microbiol. 25:45 (1987).
K. Kobayashi, M J. Blaser, and W.R. Brown, Immunohistochemical examination for mycobacteria in intestinal tissues from patients with Crohn’s disease, Gastroenterology. 96:1009 (1989).
D.H. Graham, D.C. Markesich, and H.H. Yoshimura, Mycobacteria as the cause of Crohn’s disease, Gastroenterology. 97:1354 (1989).
M.J. Blaser, W.R. Brown, and K. Kobayashi, Correspondence. Reply to letter by D.Y. Graham et al., Gastroenterology. 97:1355 (1989).
R. Marcus, and J. Watt, Seaweeds and ulcerative colitis in laboratory animals, Lancet. 2:489 (1969).
J. Watt, and R. Marcus, Carrageenan-induced ulceration of the large intestine in the guinea pig, Gut. 12:164 (1971).
A.B. Onderdonk, J.G. Bartlett, Bacteriological studies of experimental ulcerative colitis, Am J Clin Nutr. 32:258 (1979).
A.B. Onderdonk, M.L. Franklin, and R.L. Cisneros, Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora, Infect Immun. 32:225 (1981).
A.B. Onderdonk, R.L. Cisneros, and R.T. Bronson, Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus, Infect Immun. 42:783 (1983).
A.B. Onderdonk, R.M. Steeves, R.L. Cisneros, and R.T. Bronson, Adoptive transfer of immune enhancement of experimental ulcerative colitis, Infect Immun. 46:64 (1984).
J. Watt, and R. Marcus, Experimental ulcerative disease of the colon in animals, Gut. 14:506 (1973).
R.B. Sartor, W.J. Cromarties, D.W. Powell, and J.H. Schwab, Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments, Gastroenterology. 89:587 (1985).
T. Yamada, R.B. Sartor, S. Marshall, R.D. Specian, and M.B. Grisham, Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats, Gastroenterology. 104:759 (1993).
R.B. Sartor, T.M. Bond, and J.H. Schwab, Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury, Infect Immun. 56:2101 (1988).
C.J. Woolverton, E.J. Chapman, P.B. Carter, and R.B. Sartor, Systemic immunoregulation in germ free mice fed bacterial cell wall polymers, in: “Inflammatory Bowel Disease: Current Status and Future Approach,” R.P. MacDermott, ed., Elsevier Science Publishers B.V., Amsterdam (1988).
S. Okabe, K. Nakamura, K. Takeuchi, and K. Takagi, Effects of antacid, antipeptic and anticholinergic agents on the development and healing of duodenal ulcers in the rat, Digestion. 10:113 (1974).
R. Fabia, R. Willen, A. Ar’Rajab, R. Andersson, B. Ahren, and S. Bengmark, Acetic acid-induced colitis in the rat: A reproducible experimental model for acute ulcerative colitis, Eur Surg Res. 24:211 (1992).
D.R.E. Reeve, An electron microscopical study of chronic ulcers of the colon in rats. Br J Exp Path. 58:63 (1977).
C.H. Weischer, W. Jahn, and I. Szelenyi, A new model for inflammatory colonic disease induced by capsaicin in rats. Agents Actions. 26:222 (1989).
B.R. MacPherson, and C.J. Pfeiffer, Experimental production of diffuse colitis in rats, Digestion.17:135 (1978).
P.G. Davey, E.E. McGuiness, S. Nichol, and K.G. Wormsley, Experimental colitis and colonic cancer in the rat, Mt Sinai J Med. 52:209 (1984).
P. Sharon, and W.F. Stenson, Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease, Gastroenterology. 88:55 (1985).
D.J. Fretland, S. Levin, B.S. Tsai et al., The effect of leukotriene-B4 receptor antagonist, SC-41930,on acetic acid-induced colonic inflammation, Agents Actions. 27:395 (1989).
T.H.M. Stewart, C. Hetenyi, H. Rowsell, and M. Orizaga, Ulcerative enterocolitis in dogs induced by drugs, J. Pathol. 131:363 (1980).
P. Del Soldato, D. Foschi, L. Varin, and S. Daniotti, Indomethacin-induced intestinal ulcers in rats:effects of salicylazosulfapyridine and dexamethasone, Agents Actions. 16:393 (1985).
T. Yamada, E. Deitch, R.D. Specian, M.A. Perry, R.B. Sartor, and M.B. Grisham, Mechanisms of acute and chronic intestinal inflammation induced by indomethacin, Inflammation. 17:641 (1993).
H.H. LeVeen, G. Falk, and B. Schatman, Experimental ulcerative colitis produced by anticolon sera. Ann Surg. 154:275 (1961).
E.W. Rosenberg, and R.W. Fischer, DNCB allergy in the guinea pig colon, Arch Dermatol. 89:99 (1964).
R.O. Bicks, and E.W. Rosenberg, A chronic delayed hypersensitivity reaction in the guinea pig colon Gastroenterology. 46:543 (1964).
R.O. Bicks. G. Brown, H.D. Hickey, and E.W. Rosenberg, Further observations on a delayed hypersensitivity reaction in the guinea pig colon, Gastroenterology. 48:425 (1965).
R.O. Bicks, M.M. Azar, E.W. Rosenberg, W.J. Dunham, and J. Luther, Delayed hypersensitivity reactions in the intestinal tract. I. Studies of 2,4-dinitrochlorobenzene-caused guinea pig and swine colon lesions, Gastroenterology. 53:422 (1967).
R.O. Bicks, M.M. Azar, and E.W. Rosenberg, Delayed hypersensitivity reactions in the intestinal tract. II. Small intestinal lesions associated with xylose malabsorption, Gastroenterology. 53:437 (1967).
B.S. Rabin, and S.J. Rogers, A cell-mediated immune model of inflammatory bowel disease in the rabbit, Gastroenterology. 75:29 (1978).
M.S. Nemirovsky, and J.S. Hugon, Immunopathology of guinea-pig autoimmune enterocolitis induced by alloimmunisation with an intestinal protein, Gut. 27:1434 (1986).
G. Wickbom, S.-O. Cha, and P. O’Leary, Experimentally induced ileal ulcers in rats. A model to study non-specific inflammatory bowel disease, Scand J Gastroenterol. 23:808 (1988).
A.S. Mee, J.E. McLaughlin, H.J.F. Hodgson, and D.P. Jewell, Chronic immune colitis in rabbits,Gut. 20:1 (1979).
H.J.F. Hodgson, B.J. Potter, J. Skinner, and D.P. Jewell, Immune-complex mediated colitis in rabbits, Gut. 19:225 (1978).
H.W. Kao, and R.D. Zipser, Exaggerated prostaglandin production by colonic smooth muscle in rabbit colitis, Dig Dis Sci. 33:697 (1988).
N.K. Boughton-Smith, and B.J.R. Whittle, The role of eicosanoids in animal models of inflammatory bowel disease, in: “Inflammatory Bowel Diseases -Basic Research and Clinical Implications,” H. Goebell, B.M. Peskar, H. Malchow, eds., MTP Press Ltd., Lancaster, England (1988).
F. Cominelli, C.C. Nast, R. Lierena, C.A. Dinarello, and R.D. Zipser, Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins, J Clin Invest. 85:582 1990).
F. Cominelli, C.C. Nast, B.D. Clark et al., Interleukin 1 (IL-1) gene expression, synthesis and effect on specific IL-1 receptor blockade in rabbit immune complex colitis, J Clin Invest. 86:972 (1990).
F. Cominelli, C.C. Nast, A. Duchini, and M. Lee, Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis, Gastroenterology. 103:65 (1992).
K.J. Ivey, A. Tarnawski, J. Stachura, H. Werner, T. Mach, and M. Burks, The induction of gastric mucosal tolerance to alcohol by chronic administration, J Lab Clin Med. 96:922 (1980).
M. Ward, The pathogenesis of Crohn’s disease, Lancet. 903 (1977).
R.G. Shorter, K.A. Huizenga, and R.J. Spencer, A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease, Am J. Dig Dis. 17:1024 (1972).
G.P. Morris, L. Rebeiro, M.S. Herridge, M. Szewczuk, and W.T. Depew, An animal model for chronic granulomatous inflammation of the stomach and colon, Gastroenterology. 86:A1188 (1984).
T.T. Hynna, and G.P. Morris, Gastric mucosal microcirculation in a chronic ulcer model,Gastroenterology. 94:A199 (1988).
G.P. Morris, P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace,Hapten-induced model of chronic inflammation and ulceration in the rat colon, Gastroenterology. 96:795 (1989).
N.K. Boughton-Smith, J.L. Wallace, G.P. Morris, and B.J.R. Whittle, The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol. 94:65 (1988).
H. Allgayer, K. Deschryver, and W.F. Stenson, Treatment with 16,16’-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation, Gastroenterology. 96:1290 (1989).
P.L. Beck, and G.P. Morris, Acute ulceration and inflammation is required for the induction of chronic ulceration and inflammation in the colon of the rat, Gastroenterology. 96:A35 (1989).
D. Hollander, Crohn’s disease--A permeability disorder of the tight junction, Gut. 29:1621 (1988).
G. Olaison, P. Leandersson, R. Sjodahl, and C. Tagesson, Intestinal permeability to polyethyleneglycol 600 in Crohn’s disease. Perioperative determination in a defined segment of the small intestine, Gut. 29:196 (1988).
D. Hollander, CM. Vadheim, E. Brettholz, G.M. Petersen, T. Delahunty, and J.I. Rotter, Increased intestinal permeability in patients with Crohn’s disease and their relatives. A possible etiologic factor, Ann Intern Med. 105:883 (1986).
T. Yamada, S. Marshall, R.D. Specian, and M.B. Grisham, A comparative analysis of two models of colitis in rats, Gastroenterology. 102:1524 (1992).
S. Ahmad, J. Rausa, E. Jang, and E.E. Daniel, Calcium channel binding in nerves and muscle of canine small intestine, Biochem Biophys Res Commun. 159:119 (1989).
J.L. Wallace, W.K. MacNaughton, G.P. Morris, and P.L. Beck, Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease, Gastroenterology. 96:29 (1989).
R. Eliakim, F. Karmeli, E. Okon, and D. Rachmilewitz, Ketotifen effectively prevents mucosal damage in experimental colitis, Gut. 33:1498 (1992).
K. Matsueda, J.J. Rimpila, H.E. Ford, B. Levin, and S.C. Kraft, Tissue mast cells in Crohn’s disease and ulcerative colitis, in: “Recent Advances in Crohn’s Disease,” A.S. Pena, E.T. Weterman, C.C. Booth, W. Strober, eds., Martinus Nijhoff, The Hague (1981).
S.N. Rao, Mast cells as a component of the granuloma in Crohn’s disease, J. Pathol. 109:79 (1972).
A.M. Dvorak, R.A. Monahan, J.E. Osage, and G.R. Dickersin, Crohn’s disease: transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature, Human Pathology. 11:606 (1980).
M.N. Marsh, and J. Hinde, Inflammatory component of celiac sprue mucosa. I. Mast cells,basophils, and eosinophils, Gastroenterology. 89:92 (1985).
P. Ranlov, M.H. Nielsen, and J. Wanstrup, Ultrastructure of the ileum in Crohn’s disease. Immune lesions and mastocytosis, Scand J Gastroent. 1:411 (1972).
P. Brandtzaeg, Prolonged incubation time in immunohistochemistry: Effects on fluorescence staining of immunoglobulins and epithelial components in ethanol-and formaldehyde-fixed paraffin-embedded tissues, J. Histochem Cytochem. 29:1302 (1981).
A.M. Dvorak, H.F. Dvorak, S.P. Peters et al., Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells, J Immunol 131:2965 (1983).
K. Baklien, and P. Brandtzaeg, Immunohistochemical characterization of local immunoglobulin formation in Crohn’s disease of the ileum Scand J. Gastroenterol 11:447 (1976).
P.C.M. Rosekrans, C.J.L.M. Meijer, A.M. Van der Wal, C.J. Cornelisse, J. Lindeman,Immunoglobulin containing cells in inflammatory bowel disease of the colon: a morphometric and immunohistochemical study, Gut. 21:941 (1980).
P.L. Beck, A.W. Wade, and G.P. Morris, Chronic inflammation in the rat colon: a comparison of different haptens, Gastroenterology. 96:A35 (1989).
G.P. Morris, M.S. Herridge, P.L. Beck, and L.R. Rebeiro, An animal model for colonic Crohn’s disease, Dig Dis Sci. 30:389 (1985).
D J.G. White, Cyclosporin A. Clinical pharmacology and therapeutic potential Drugs. 24:322 (1982).
D.B. Sachar, and D.H. Present, Immunotherapy in inflammatory bowel disease, Med Clin N Amer.62:173 (1978).
J. Brynskov, L. Freund, O.O. Thomsen, C.B. Andersen, S.N. Rasmussen, and V. Binder, Treatment of refractory ulcerative colitis with cyclosporin enemas, Lancet. 1:721 (1989).
H. Hoshino, S. Sugiyama, A. Ohara, H. Goto, Y. Tsukamoto, and T. Ozawa T, Mechanism and prevention of chronic colonic inflammation with trinitrobenzene sulfonic acid in rats, Clin Exp Pharmacol Physiol. 19:717 (1992).
K.R. Gardiner, P.J. Erwin, N.H. Anderson, J.G. Barr, M.I. Halliday, and B.J. Rowlands, Colonic bacteria and bacterial translocation in experimental colitis, Br J Surg. 80:512 (1993).
D. Rachmilewitz, P.L. Simon, L.W. Schwartz, D.E. Griswold, J.D. Fondacaro, and M.A.Wasserman, Inflammatory mediators of experimental colitis in rats, Gastroenterology. 97:326 (1989).
K.J. McHugh, H.P. Weingarten, C. Keenan, J.L. Wallace, and S.M. Collins, On the suppression of food intake in experimental models of colitis in the rat, Am J. Physiol Regul Integr Comp Physiol. 264:R871 (1993).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Morris, G.P., Beck, P.L., Wallace, J.L., Herridge, M.S., Fallone, C.A. (1995). Animal Models and Pathogenesis of Inflammatory Bowel Disease. In: Szabo, S., Taché, Y., Glavin, G.B. (eds) Neuroendocrinology of Gastrointestinal Ulceration. Hans Selye Symposia on Neuroendocrinology and Stress, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1867-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1867-9_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5759-9
Online ISBN: 978-1-4615-1867-9
eBook Packages: Springer Book Archive